Page last updated: 2024-09-05

melagatran and Hyperlipidemias

melagatran has been researched along with Hyperlipidemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bea, F; Blessing, E; Isermann, B; Katus, H; Kreuzer, J; Preusch, M; Rosenfeld, ME; Schaab, S	1

Other Studies

1 other study(ies) available for melagatran and Hyperlipidemias

Article	Year
Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:12 Topics: Animals; Anticoagulants; Apolipoproteins E; Atherosclerosis; Azetidines; Benzylamines; Carotid Stenosis; Disease Progression; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Hyperlipidemias; Lipids; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Thrombin; Transcription Factor AP-1	2006

Article

Year

Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.

Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:12

Topics: Animals; Anticoagulants; Apolipoproteins E; Atherosclerosis; Azetidines; Benzylamines; Carotid Stenosis; Disease Progression; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Hyperlipidemias; Lipids; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Thrombin; Transcription Factor AP-1

2006